Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (155)
ARTG (438)
Prescription medicine registration (28)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (4)
2024 (30)
2023 (4)
2022 (18)
2021 (17)
2020 (4)
2019 (22)
2018 (40)
2017 (16)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

155 result(s) found, displaying 131 to 140

IRBESARTAN/HCTZ RBX 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN/HCTZ RBX 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN RBX irbesartan 150 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN RBX irbesartan 300 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
SEBIFIN terbinafine (as hydrochloride) 250 mg tablet blister pack Cancelled under s30(1)(c) of the Act

5 February 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
DONEPEZIL GENERICHEALTH donepezil hydrochloride (as monohydrate) 10 mg tablet blister pack Cancelled under s30(1)(c) of the Act

5 February 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ATENOLOL RBX Atenolol 50 mg film coated tablets blister pack Cancelled under s30(1)(c)

9 January 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
MEMANTINE RBX memantine hydrochloride 20 mg tablet blister pack Cancelled under s30(1)(c)

9 January 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
MEMANTINE RBX memantine hydrochloride 10 mg tablet blister pack Cancelled under s30(1)(c)

9 January 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
DONEPEZIL RBX donepezil hydrochloride (as monohydrate) 5 mg tablet blister pack Cancelled under s30(1)(c)

30 October 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Current page 14
Page 15
Page 16
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.